Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Euro Q2 Earnings Preview: GSK, Sanofi, Bayer And Reckitt

Jul 21 2021

• By Tom Gallen

Q2 written on a speechbubble — • Source: Shutterstock

Related Content

OTC Zantac Recall: Sanofi Heeds To Potential Ranitidine Contaminant

Oct 18 2019

COVID-19 Ibuprofen Fears Hit Advil Sales In GSK’s Q2

Jul 30 2020

RB Predicts 'Challenging' Rest Of Year For OTC Business

Jul 29 2020

Sanofi Consumer Sales Slow As Pandemic-Driven Surge Ends, But OTC Xyzal Line Still Shines

Jul 29 2020

Bayer Sees Positive Consumer Change From COVID-19 Despite Slowing Sales

Aug 05 2020

Bayer Cements Supplement Sales Gains From Initial COVID Boost

May 13 2021

Activist Investor Urges GSK To Consider Consumer Healthcare Sale

Jul 01 2021

US Q2 Consumer Health Earnings Preview: Will More Favorable Year-Ago Comparisons Help?

Jul 20 2021

GSK Remains Open To Consumer Healthcare Sale As It Prepares To Name CEO

Jul 05 2021

Sanofi Returning Zantac OTC Heartburn Remedy Brand To US Market Formulated With Famotidine

Apr 28 2021

GSK Sees Other Side Of Consumer Health Stockpiling Coin, Looks Ahead To Business Split

Apr 28 2021

Reckitt's OTC Sales Slide 40% In 'Exceptionally Weak' Cold & Flu Season

Apr 28 2021

OTC Allergy Switch Approved For Bayer In US

Jun 17 2021

Reckitt Offloads Troubled Chinese Infant Nutrition Business

Jun 09 2021

Additional Topics

Europe Sales & Earnings Business Strategies Dietary Supplements OTC Drugs Consumer

More from Earnings

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window